Empyrean Bioscience Announces Preventx Effective Against Anthrax in Laboratory Tests
``We are very excited to receive in vitro test results from an independent laboratory that demonstrate the effectiveness of Preventx® against anthrax,'' said Richard C. Adamany, Empyrean's president and chief executive officer. ``Of course, we will need to do further studies and obtain FDA approval to market Preventx® for this indication.''
``This successful test is the most recent in a series of bioterrorism susceptibility tests managed by Focus Technologies for the biopharmaceutical industry. We have been able to determine, in vitro, the effectiveness of most commercially available antibiotic products in combating anthrax and other potential bioterrorism agents,'' commented Daniel Sahm, Ph.D., Focus' chief scientific officer.
Preventx® hand sanitizer and first-aid antiseptic lotion features an alcohol-free, aloe-enriched formula that kills 99.9% of most common disease-causing germs for up to four hours, and is available nationally at Walgreens, Rite Aid and Eckerd, and regionally at Fred Meyer, Longs Drug, Duane Reade, Weiss Markets, Marc's, Medic Drug, Heinen's Fine Foods and other fine retailers nationwide.
Most read news
Other news from the department science
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.